Weekly CEO & CFO Moves Update
Here is a look at this week’s CEO and CFO moves at US public companies. At Accuray Inc., Suzanne C. Winter stepped down after a 2.2-year tenure as CEO, during which the company experienced a -1.0% total shareholder return (TSR). Sandeep Chalke, the Senior Vice President and Chief Commercial Officer since May 2022, has been named interim CEO. Meanwhile, at Azenta Inc., Stephen S. Schwartz is being replaced by John Marotta as CEO after nearly 14 years, during which the company achieved a strong 18.2% TSR.
Several companies are seeing incoming leaders with a broad range of industry experience. At Bloomin’ Brands Inc., Michael Spanos takes over as CEO from David J. Deno, who served for 5.4 years with a -1.0% TSR. Spanos has held leadership roles at Delta Airlines, Six Flags Entertainment, and PepsiCo. At Chipotle Mexican Grill Inc., Scott Boatwright, who joined the company in 2017 and played a key role in restaurant operations, is stepping in as interim CEO following Brian R. Niccol’s 6.4-year tenure, which yielded an impressive 40.1% TSR. Additionally, Fortive Corp. has appointed Olumide Soroye as its new CEO, succeeding James A. Lico, who leaves after over eight years with a positive TSR of 6.9%.
Other transitions include CFO changes, such as at Lexaria Bioscience Corp., where Christopher Bunka is stepping down as CEO after nearly 18 years, with Richard Christopher taking over the role. Also of note, Talos Energy Inc. has named Joseph A. Mills as interim CEO, succeeding Timothy S. Duncan after a -16.7% TSR over his 6.3-year leadership.
This Week’s CEO and CFO Moves
| COMPANY | MARKET CAP / TSR | ROLE | LEAVING | JOINING | JOINER BIOGRAPHY |
|---|---|---|---|---|---|
| ACCURAY INC ARAY |
Mkt Cap: $197.5M 1-Yr TSR: -30.2% |
CEO | Suzanne C Winter 2.2 yrs -1.0% TSR |
Sandeep Chalke (interim) |
Mr. Chalke, age 58, has served as the Company’s Senior Vice President, Chief Commercial Officer since May 2022. Prior to joining the Company, Mr. Chalke served as President, Asia-Pacific and Latin America regions at Vyaire Medical, Inc., a private global respiratory care manufacturer, from April 2020 to May 2022. Prior to that, he was Vice President of the Diabetes Group in Asia Pa…read full bio |
| ATLASSIAN CORP TEAM |
Mkt Cap: $42.1B 1-Yr TSR: -21.4% |
Co-CEO | Scott Farquhar 1.9 yrs -23.9% TSR |
Moving to single CEO | Moving to single CEO |
| AZENTA INC AZTA |
Mkt Cap: $2.3B 1-Yr TSR: -12.6% |
CEO | Stephen S Schwartz 13.9 yrs 18.2% TSR |
John Marotta | Mr. Marotta, age 44, most recently served as Executive in Residence at Patient Square Capital from February 2023 to August 2024. He previously served as the President and Chief Executive Officer of PHC Group, a diversified global life sciences, diagnostics and medical device company focused on precision healthcare, from December 2020 to May 2022. Before being promoted to Chief Executive Officer of…read full bio |
| BLOOMIN’ BRANDS INC BLMN |
Mkt Cap: $1.4B 1-Yr TSR: -33.7% |
CEO | David J Deno 5.4 yrs -1.0% TSR |
Michael Spanos | Mr. Spanos, 59, served as Chief Operating Officer of Delta Airlines from June 2023 to August 2024; Owner of Mike Spanos Associates, a business consulting firm, from January 2022 to May 2023; and President and Chief Executive Officer of Six Flags Entertainment Corporation from November 2019 to November 2021. Prior to joining Six Flags, he spent more than 25 years in a variety of positions at PepsiC…read full bio |
| CHIPOTLE MEXICAN GRILL INC CMG |
Mkt Cap: $72.6B 1-Yr TSR: 35.9% |
CEO | Brian R Niccol 6.4 yrs 40.1% TSR |
Scott Boatwright (interim) |
Boatwright joined Chipotle in 2017 and has been instrumental in driving restaurant operations for the company’s more than 120,000 employees and over 3,500 restaurants. He also led the integration of new technology into restaurants, built a strong culture aligned to the organization’s values, and achieved industry-leading retention rates yielding impressive results and improvements in throughput an…read full bio |
| FORTIVE CORP FTV |
Mkt Cap: $25.5B 1-Yr TSR: -5.7% |
CEO | James A Lico 8.3 yrs 6.9% TSR |
Olumide Soroye | Olumide Soroye has served as President and CEO of Intelligent Operating Solutions since August 2021. Prior to joining Fortive, Mr. Soroye was the Managing Director of the Property Intelligence and Risk Management segment of CoreLogic from September 2013 to August 2021….read full bio |
| FOSSIL GROUP INC FOSL |
Mkt Cap: $54.2M 1-Yr TSR: -51.9% |
CEO | Jeffrey N Boyer .5 yrs *interim* 3.0% TSR |
Franco Fogliato | Mr. Fogliato, age 55, most recently served as President and Chief Executive Officer of Salomon, a division of Amer Sports, Inc. (NYSE: AS), from November 2021 until April 2024. Amer Sports designs, manufactures, markets, distributes and sells sports equipment, apparel, footwear and accessories. Previously, from November 2013 to October 2021, Mr. Fogliato served in various roles for Columbia Sports…read full bio |
| LEXARIA BIOSCIENCE CORP LEXX |
Mkt Cap: $52.2M 1-Yr TSR: 247.4% |
CEO | Christopher Bunka 17.8 yrs -17.9% TSR |
Richard Christopher | Mr. Christopher was the Chief Financial Officer of iCAD, Inc. from December 2016 through January 2019. iCAD, Inc. is a Nasdaq-listed company with a focus on therapies and solutions for the early identification and treatment of cancer, where he held both financial and operational responsibilities. Prior to iCAD, Inc., Mr. Christopher was Chief Fin…read full bio |
| NOVOCURE LTD NVCR |
Mkt Cap: $2.0B 1-Yr TSR: -15.7% |
CEO | Asaf Danziger 22.2 yrs -1.9% TSR |
Ashley Cordova | Ashley Cordova has been our Chief Financial Officer since September 2020. From October 2018 to August 2020, Ms. Cordova served as our Senior Vice President, Finance and Investor Relations. Ms. Cordova joined us in June 2014 as Director of Global Treasury. In March 2015, she became our Senior Director, Investor Relations and Global Treasury, and in July 2016, she became our Vice President, Finance…read full bio |
| REPLIGEN CORP RGEN |
Mkt Cap: $8.1B 1-Yr TSR: -14.3% |
CEO | Anthony Hunt 9.3 yrs 18.3% TSR |
Olivier Loeillot | Mr. Loeillot currently oversees the Company’s four business units and the global commercial organization. His focus since joining Repligen has been on driving the commercial and corporate key accounts strategy, participating in strategic planning and evaluating potential business development opportunities. A nearly 30-year industry veteran, Mr. Loeillot previously served…read full bio |
| TALOS ENERGY INC TALO |
Mkt Cap: $1.9B 1-Yr TSR: -37.1% |
CEO | Timothy S Duncan 6.3 yrs -16.7% TSR |
Joseph A Mills (interim) |
Mr. Mills, age 64, has over 42 years of experience in all facets of the oil and gas energy business. Mr. Mills currently serves as a member of the Board and several other private E&P companies. In addition, Mr. Mills serves as the Chief Executive Officer of Samson Resources II, LLC, a position he has held since March 2017. Prior to joining Samson Resources, Mr. Mills served in various roles, inclu…read full bio |
| TD SYNNEX CORP SNX |
Mkt Cap: $9.7B 1-Yr TSR: 14.7% |
CEO | Richard T Hume 3.0 yrs -.9% TSR |
Patrick Zammit | Zammit, who has served as the company’s chief operating officer since January 2024, brings a wealth of experience and a proven track record of driving growth and operational excellence. Zammit has been instrumental in coordinating the company’s business strategy, driving profitable growth and accelerating the adoption of new, high-growth technologies around the globe. Zammit led the Eu…read full bio |
| TIMKEN CO TKR |
Mkt Cap: $5.5B 1-Yr TSR: 5.5% |
CEO | Richard G Kyle 10.3 yrs 8.8% TSR |
Tarak Mehta | Mr. Mehta, age 57, currently serves as President, Motion Business Area and a Member of the Group Executive Committee of ABB Ltd, a technology leader in electrification and automation. During his 26-year career with ABB, Mr. Mehta has held a variety of roles of increasing responsibility, including President Electrification Products (2015-2022) and President Low Voltage Products (2010-2015), among o…read full bio |
| XWELL INC XWEL |
Mkt Cap: $9.3M 1-Yr TSR: -52.5% |
CEO | Scott R Milford 2.7 yrs -65.9% TSR |
Ezra Ernst | Prior to his appointment as President and Chief Executive Officer of the Company, Mr. Ernst served as the Executive Vice President of the Company and Chief Executive Officer of the Company’s subsidiary XpresTest, Inc. since the Company’s January 2022 acquisition of GCG Connect LLC d/b/a HyperPointe. Mr. Ernst also has served as President and Chief Executive Officer of HyperPointe since…read full bio |
| ALDEYRA THERAPEUTICS INC ALDX |
Mkt Cap: $375.5M 1-Yr TSR: -12.2% |
CFO | Bruce Greenberg 2.3 yrs *interim* 5.9% TSR |
Michael Alfieri | Mr. Alfieri has served as a consultant with Danforth, a provider of strategic and operational finance and accounting for life science companies, since September 2019, where he provides financial consulting services to both public and private pharma and biotechnology companies. Prior to then, Mr. Alfieri served as Vice President, Finance and Principal Financial Officer of Genocea Bio…read full bio |
| AMERESCO INC AMRC |
Mkt Cap: $1.7B 1-Yr TSR: -27.1% |
CFO | Spencer Doran Hole 5.1 yrs 14.1% TSR |
Mark Chiplock | Mr. Chiplock joined the Company as Corporate Controller in June 2014 and became Vice President, Finance in April 2016. From October 1, 2018 until July 1, 2019 he served as the Company’s Interim Chief Financial Officer and Chief Accounting Officer after which he continued to serve as Vice President, Chief Accounting Officer and in February 2022 was promoted to Senior Vice President, Chief Acc…read full bio |
| ASANA INC ASAN |
Mkt Cap: $2.9B 1-Yr TSR: -41.9% |
CFO | Tim M Wan 7.7 yrs -17.6% TSR |
Sonalee Elizabeth Parekh | Ms. Parekh, age 51, most recently served as Chief Financial Officer of RingCentral, Inc., a cloud-based collaboration and communication SaaS company, from May 2022 through August 2024, where she was responsible for accounting, FP&A, treasury, tax, internal audit and investor relations. Previously, Ms. Parekh served as Divisional CFO and Senior Vice President of Corporate Development and Invest…read full bio |
| CIENA CORP CIEN |
Mkt Cap: $7.6B 1-Yr TSR: 9.4% |
CFO | James E Moylan Jr 17.7 yrs 1.1% TSR |
TBD | Plans to retire by August 28, 2025. Search underway for new CFO. |
| ELICIO THERAPEUTICS INC ELTX |
Mkt Cap: $43.0M 1-Yr TSR: -52.6% |
CFO | Brian Piekos 1.3 yrs -37.8% TSR |
TBD | TBD |
| EVERCOMMERCE INC EVCM |
Mkt Cap: $1.9B 1-Yr TSR: .5% |
CFO | Marc Christopher Thompson 3.2 yrs -15.2% TSR |
Ryan H Siurek | Mr. Siurek, 52, has served as the Company’s Chief Accounting Officer since July 2023. Mr. Siurek has over 30 years of finance and accounting operational experience in public companies from emerging growth companies to the Fortune 100. Prior to his role as Chief Accounting Officer at the Company, Mr. Siurek served as the Chief Accounting Officer of Biodesix, Inc. (“Biodes…read full bio |
| EXAGEN INC XGN |
Mkt Cap: $59.5M 1-Yr TSR: 37.6% |
CFO | John Aballi *interim* |
Jeffrey G Black | Mr. Black currently serves as Chief Financial Officer of Standard BioTools Inc., a publicly traded, biological research equipment company. Previously to this role, Mr. Black served as Senior Vice President and Chief Financial Officer of Apollo Endosurgery Inc., a publicly traded, medical technology company focused on endoscopic therapies for gastrointestinal conditions and interventional treatment…read full bio |
| EYENOVIA INC EYEN |
Mkt Cap: $32.9M 1-Yr TSR: -73.1% |
CFO | John P Gandolfo 6.7 yrs -32.2% TSR |
Andrew D Jones | Mr. Jones (age 54) served as the Chief Executive Officer and Treasurer of NovaBay Pharmaceuticals, Inc. (NYSE: NBY; “NovaBay”), an ophthalmic commercial stage company, from May 2020 to February 2023. Prior to joining NovaBay, Mr. Jones served as the Vice President of Finance of MyoScience, Inc., a commercial stage company that produced pain management devi…read full bio |
| FORTIVE CORP FTV |
Mkt Cap: $25.5B 1-Yr TSR: -5.7% |
CFO | Charles E McLaughlin 9.4 yrs 6.9% TSR |
TBD | To retire first quarter of 2025. |
| GENTHERM INC THRM |
Mkt Cap: $1.5B 1-Yr TSR: -18.6% |
CFO | Matteo Anversa 5.7 yrs 3.2% TSR |
Phillip Eyler (interim) |
Mr. Eyler also will continue to serve as President and Chief Executive Officer of the Company, as well as on the Company’s Board, which positions he has held since December 2017. Mr. Eyler will be the Company’s principal financial officer during his interim service and will continue to be the Company’s principal executive officer. Mr. Eyler also serves as an indepe…read full bio |
| GRAFTECH INTERNATIONAL LTD EAF |
Mkt Cap: $154.8M 1-Yr TSR: -83.0% |
CFO | Catherine Hedoux-Delgado .8 yrs *interim* -80.1% TSR |
Rory F O’Donnell | Mr. O’Donnell previously served as Senior Vice President, Controller and Principal Accounting Officer of Covia Corporation, a provider of mineral-based and material solutions for the industrial and energy markets, since February 2019. While at Covia Corporation, he also served as Interim Chief Financial Officer from August 2022 to July 2023. Prior to Covia Corporation, Mr. O’Donnell se…read full bio |
| INTELLICHECK INC IDN |
Mkt Cap: $40.8M 1-Yr TSR: -23.4% |
CFO | Jeffrey Ishmael 2.3 yrs 1.4% TSR |
Adam Sragovicz | Prior to joining the Company, Mr. Sragovicz was most recently Chief Financial Officer of Murphy Canyon Acquisition Corp., a blank check special purpose acquisition company, from October 2021 through its business combination with Conduit Pharmaceuticals Limited in September 2023, from which point he served as the Chief Financial Officer of the combined company, Conduit Pharmaceuticals, Inc., a clin…read full bio |
| IRHYTHM TECHNOLOGIES INC IRTC |
Mkt Cap: $2.0B 1-Yr TSR: -34.5% |
CFO | Brice Bobzien 2.1 yrs -23.4% TSR |
Daniel Wilson | Mr. Wilson, age 42, has served as the Company’s Executive Vice President, Corporate Development and Investor Relations since April 2023 and previously served as Executive Vice President, Corporate Development, Corporate Strategy and Investor Relations from June 2019 to April 2023. Previously, he served as Director and Head of Business Development at Penumbra, Inc., a global healthcare compan…read full bio |
| KILROY REALTY CORP KRC |
Mkt Cap: $4.1B 1-Yr TSR: .5% |
CFO | Eliott Trencher 2.6 yrs *interim* -17.8% TSR |
Jeffrey Kuehling | Jeffrey Kuehling, age 39, joins the Company from Brixmor Property Group (“Brixmor”), a publicly-traded real estate investment trust, where he has served as the Vice President, Corporate Strategy and then the Senior Vice President, Corporate Strategy since 2018. Prior to Brixmor, Mr. Kuehling served as the Director of Corporate Finance at RPT Realty and held several finance positio…read full bio |
| LIFECORE BIOMEDICAL INC LFCR |
Mkt Cap: $141.5M 1-Yr TSR: -41.5% |
CFO | John D Morberg 3.7 yrs -18.0% TSR |
Ryan David Lake | Mr. Lake, age 47, most recently served as the Chief Financial Officer of Societal CDMO, Inc., a bi-coastal contract development and manufacturing organization, or CDMO, with capabilities spanning pre-investigational new drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus on small molecules. Mr. Lake served as the Chief Financ…read full bio |
| LOGITECH INTERNATIONAL SA LOGI |
Mkt Cap: $13.1B 1-Yr TSR: 22.3% |
CFO | Meeta Sunderwala .3 yrs *interim* |
Matteo Anversa | Mr. Anversa, age 52, served as Executive Vice President of Finance, Chief Financial Officer and Treasurer of Gentherm Incorporated, a thermal management technology company, from January 2019 to August 2024. Prior to joining Gentherm, Mr. Anversa served as Executive Vice President and Chief Financial Officer of Myers Industries, Inc., an international manufacturer of polymer-based material handling…read full bio |
| MUELLER WATER PRODUCTS INC MWA |
Mkt Cap: $3.1B 1-Yr TSR: 47.1% |
CFO | Steven S Heinrichs 1.3 yrs 24.6% TSR |
TBD | TBD |
| NORTHWEST NATURAL HOLDING CO NWN |
Mkt Cap: $1.5B 1-Yr TSR: 5.6% |
CFO | Brody J Wilson 1.1 yrs *interim* -5.7% TSR |
Raymond J Kaszuba III | Mr. Kaszuba, 45, joins NW Holdings and NW Natural from AmeriGas, the United States’ largest propane distributor and a subsidiary of UGI Corporation, where he has been serving as Interim President since November 2023. He has been with AmeriGas since October 2022, serving as Vice President and Chief Financial Officer prior to assuming his role as Interim President. Prior to AmeriGas, Mr.&…read full bio |
| PLANET FITNESS INC PLNT |
Mkt Cap: $7.0B 1-Yr TSR: 34.0% |
CFO | Thomas J Fitzgerald III 4.7 yrs 1.6% TSR |
TBD | Will remain with the company through December 2024 while company completes search for new CFO. |
| RINGCENTRAL INC RNG |
Mkt Cap: $2.7B 1-Yr TSR: -8.1% |
CFO | Sonalee Elizabeth Parekh 2.3 yrs -38.2% TSR |
TBD | Departing to accept a Chief Financial Officer role at a public company that is not a competitor. |
| STANDARD BIOTOOLS INC LAB |
Mkt Cap: $727.5M 1-Yr TSR: -34.9% |
CFO | Jeffrey G Black 1.3 yrs .5% TSR |
Hanjoon Alex Kim (interim) |
Hanjoon Alex Kim joined the Company as Chief Operating Officer on April 4, 2022. Prior to joining the Company, Mr. Kim served as the chief business officer of Standard BioTools, LLC, a life science tools company, since October 2021. Previously, he served in various roles at Milliken & Company (“Milliken”) from October 2015 to May 2021, including executive vice president and president of the Health…read full bio |
| VOYA FINANCIAL INC VOYA |
Mkt Cap: $7.0B 1-Yr TSR: 7.2% |
CFO | Donald C Templin 2.1 yrs 4.3% TSR |
Michael Robert Katz | Michael Katz, age 48, will assume the role of Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2025. Mr. Katz currently serves as Executive Vice President, Finance, of the Company, a position he has held since November 2022. Prior to this, he served as Chief Strategy, Planning and Investor Relations Officer from January 2020 (as an Executive Vice…read full bio |
| VSE CORP VSEC |
Mkt Cap: $1.6B 1-Yr TSR: 57.8% |
CFO | Tarang Sharma .3 yrs *interim* |
Adam Cohn | Mr. Cohn, age 38, previously served as Chief Financial Officer at Valence Surface Technologies, a surface finishing company specializing in the commercial aerospace, defense, space and satellite industries (2022 to 2024). Prior to that, Mr. Cohn held various finance leadership roles at Triumph Group, a global aerospace company offering design, production and services for aircraft systems and compo…read full bio |
| WABASH NATIONAL CORP WNC |
Mkt Cap: $831.1M 1-Yr TSR: -13.6% |
CFO | Michael N Pettit 4.7 yrs 7.2% TSR |
Patrick Keslin | Mr. Keslin, age 44, was appointed Vice President Finance on September 4, 2022. He previously served as Senior Director of Business Finance from April 2019 to September 2022. Mr. Keslin joined the Company in 2017 and has held a number of positions with increasing responsibility, including Director of Finance – Diversified Products Group and Senior Director of Finance – Commercial Traile…read full bio |
| WHEELS UP EXPERIENCE INC UP |
Mkt Cap: $1.2B 1-Yr TSR: -33.6% |
CFO | Todd Lamar Smith 2.3 yrs -67.9% TSR |
Eric Cabezas (interim) |
Eric Cabezas, age 37, the Company’s Senior Vice President of Finance, will serve as interim Chief Financial Officer and principal accounting officer effective as of Mr. Jacobs’ departure. The Company has engaged Russell Reynolds Associates to conduct an external search for a permanent replacement for Mr. Jacobs. Mr. Cabezas has served as Wheels Up’s Senior Vice President of Finan…read full bio |
| ZOOMINFO TECHNOLOGIES INC ZI |
Mkt Cap: $3.6B 1-Yr TSR: -45.1% |
CFO | Peter Cameron Hyzer 4.8 yrs -31.8% TSR |
Michael Graham O’Brien (interim) |
With a successful track record spanning various senior leadership roles, Mr. O’Brien brings extensive expertise in financial planning and analysis, accounting, and driving strategic corporate initiatives. At ZoomInfo, he serves as Vice President of FP&A, overseeing financial forecasting, budgeting, and reporting processes. Previously, Mr. O’Brien held roles at DiscoverOrg, RainKing…read full bio |
| ZYMEWORKS INC ZYME |
Mkt Cap: $835.5M 1-Yr TSR: 60.4% |
CFO | Kenneth Galbraith .5 yrs *interim* -6.0% TSR |
Leone D Patterson | Prior to joining Zymeworks, Ms. Patterson served as Chief Financial and Business Officer at Tenaya Therapeutics where she led corporate finance, investor relations, corporate communications, strategy and business development teams as well as other operational functions. She previously held leadership positions at Adverum Biotechnologies including Chief Financial Officer, President, Chief Exec…read full bio |